Literature DB >> 21555542

Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I.

Alessandro Zarpellon1, Reha Celikel, James R Roberts, Richard A McClintock, G Loredana Mendolicchio, Kevin L Moore, Hua Jing, Kottayil I Varughese, Zaverio M Ruggeri.   

Abstract

The involvement of exosite I in α-thrombin (FIIa) binding to platelet glycoprotein Ibα (GPIbα), which could influence interactions with other substrates, remains undefined. To address the problem, we generated the GPIbα amino terminal domain (GPIbα-N) fully sulfated on three tyrosine residues and solved the structure of its complex with FIIa. We found that sulfotyrosine (Tys) 278 enhances the interaction mainly by establishing contacts with exosite I. We then evaluated how substituting tyrosine with phenylalanine, which cannot be sulfated, affects FIIa binding to soluble or surface-immobilized GPIbα-N. Mutating Tyr(276), which mostly contacts exosite II residues, markedly reduced FIIa interaction with both soluble and immobilized GPIbα-N; mutating Tyr(278) or Tyr(279), which mostly contact exosite I residues, reduced FIIa complexing in solution by 0-20% but affinity for immobilized GPIbα-N 2 to 6-fold, respectively. Moreover, three exosite I ligands--aptamer HD1, hirugen, and lepirudin--did not interfere with soluble FIIa complexing to GPIbα-N, excluding that their binding caused allosteric effects influencing the interaction; nonetheless, all impaired FIIa binding to immobilized GPIbα-N and platelet GPIb nearly as much as aptamer HD22 and heparin, both exosite II ligands. Bound HD1 and hirugen alter Trp(148) orientation in a loop near exosite I preventing contacts with the sulfate oxygen atoms of Tys(279). These results support a mechanism in which binding occurs when the two exosites of one FIIa molecule independently interact with two immobilized GPIbα molecules. Through exosite engagement, GPIbα may influence FIIa-dependent processes relevant to hemostasis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555542      PMCID: PMC3102361          DOI: 10.1073/pnas.1017042108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The biology and enzymology of protein tyrosine O-sulfation.

Authors:  Kevin L Moore
Journal:  J Biol Chem       Date:  2003-05-02       Impact factor: 5.157

Review 2.  The GPIbalpha-thrombin interaction: far from crystal clear.

Authors:  Karen Vanhoorelbeke; Hans Ulrichts; Roland A Romijn; Eric G Huizinga; Hans Deckmyn
Journal:  Trends Mol Med       Date:  2004-01       Impact factor: 11.951

3.  The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments.

Authors:  M Handa; K Titani; L Z Holland; J R Roberts; Z M Ruggeri
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

4.  Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface.

Authors:  T Okumura; M Hasitz; G A Jamieson
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

Review 5.  Von Willebrand factor.

Authors:  Zaverio M Ruggeri
Journal:  Curr Opin Hematol       Date:  2003-03       Impact factor: 3.284

6.  Refined structure of the hirudin-thrombin complex.

Authors:  T J Rydel; A Tulinsky; W Bode; R Huber
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

7.  Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation.

Authors:  John J Dumas; Ravindra Kumar; Jasbir Seehra; William S Somers; Lidia Mosyak
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

8.  Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha.

Authors:  Reha Celikel; Richard A McClintock; James R Roberts; G Loredana Mendolicchio; Jerry Ware; Kottayil I Varughese; Zaverio M Ruggeri
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

9.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

10.  Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.

Authors:  John J Dumas; Ravindra Kumar; Thomas McDonagh; Francis Sullivan; Mark L Stahl; William S Somers; Lidia Mosyak
Journal:  J Biol Chem       Date:  2004-03-23       Impact factor: 5.157

View more
  19 in total

1.  Platelet mimetic particles for targeting thrombi in flowing blood.

Authors:  Nishit Doshi; Jennifer N Orje; Blanca Molins; Jeffrey W Smith; Samir Mitragotri; Zaverio M Ruggeri
Journal:  Adv Mater       Date:  2012-05-29       Impact factor: 30.849

Review 2.  14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

Authors:  Yunfeng Chen; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

3.  The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.

Authors:  Conglei Li; Siavash Piran; Pingguo Chen; Sean Lang; Alessandro Zarpellon; Joseph W Jin; Guangheng Zhu; Adili Reheman; Dianne E van der Wal; Elisa K Simpson; Ran Ni; Peter L Gross; Jerry Ware; Zaverio M Ruggeri; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

Review 4.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

5.  Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.

Authors:  Kristine S Alexander; Michael G Fried; David H Farrell
Journal:  Biochemistry       Date:  2012-04-15       Impact factor: 3.162

Review 6.  von Willebrand factor, Jedi knight of the bloodstream.

Authors:  Timothy A Springer
Journal:  Blood       Date:  2014-06-13       Impact factor: 22.113

7.  Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib.

Authors:  Mark A Blenner; Xianchi Dong; Timothy A Springer
Journal:  J Biol Chem       Date:  2014-01-03       Impact factor: 5.157

8.  Structural and energetic determinants of tyrosylprotein sulfotransferase sulfation specificity.

Authors:  Praveen Nedumpully-Govindan; Lin Li; Emil G Alexov; Mark A Blenner; Feng Ding
Journal:  Bioinformatics       Date:  2014-05-02       Impact factor: 6.937

9.  Humanized GPIbα-von Willebrand factor interaction in the mouse.

Authors:  Sachiko Kanaji; Jennifer N Orje; Taisuke Kanaji; Yuichi Kamikubo; Yosuke Morodomi; Yunfeng Chen; Alessandro Zarpellon; Jerome Eberhardt; Stefano Forli; Scot A Fahs; Rashmi Sood; Sandra L Haberichter; Robert R Montgomery; Zaverio M Ruggeri
Journal:  Blood Adv       Date:  2018-10-09

10.  Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.

Authors:  E K Koltsova; P Sundd; A Zarpellon; H Ouyang; Z Mikulski; A Zampolli; Z M Ruggeri; K Ley
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.